comparemela.com

Latest Breaking News On - Head of corporate marketing financial communications - Page 22 : comparemela.com

Bryan Garnier & Co Initiates the Coverage of Median Technologies with a Buy Recommendation

Regulatory News: Median Technologies (ALMDT) announces today the publication of an initiation report by Bryan Garnier Co, a pan-European investment bank focusing on growth companies. In the initiation

New yorkUnited statesFrance generalCity ofUnited kingdomEmmanuelle leyguesGhislaine gasparettoCaroline carmagnolBryan garnier coLondon stock exchangeBusiness servicesHead of corporate marketing financial communicationsGarnier coRegulatory newsLondon stockMedian technologies

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31st, 2022

Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares

France generalEmmanuelle leyguesGhislaine gasparettoCaroline carmagnolHead of corporate marketing financial communicationsMedian technologiesArtificial intelligenceEuronext growthEuronext european rising techCorporate marketing financial communications

Median Technologies to Present an Abstract at the 2022 ASCO Annual Meeting, June 3 - 7, 2022, McCormick Place, Chicago, IL, USA

Regulatory News: Median Technologies (ALMDT) announced today that it will be presenting an abstract at the 2022 ASCO Annual Meeting, June 3-7, McCormick Place, Chicago, IL, USA (exhibition dates:

Mccormick placeUnited statesFrance generalEmmanuelle leyguesGhislaine gasparettoCaroline carmagnolHead of corporate marketing financial communicationsAmerican society of clinical oncologyRegulatory newsBlinded independent central reviewGastrointestinal cancerSaturday juneMccormick place southPoster boardExhibit hallAmerican society

Median Technologies Launches Imaging Lab, Spearheading the Integration of iBiopsy Artificial Intelligence Technologies Into iCRO Imaging Services for Oncology Trials

With Imaging Lab, Median will provide biopharmaceutical companies with new decision-making tools for clinical trials by leveraging images with data mining and Artificial Intelligence (AI) technologies

France generalUnited statesEmmanuelle leyguesNicolas danoGhislaine gasparettoCaroline carmagnolHead of corporate marketing financial communicationsImaging labWith imaging labArtificial intelligenceExhibit hallFredrik bragChicago medianMedian technologiesEuronext growthEuronext european rising tech

Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy Lung Cancer Screening CADe/CADx Software as Medical Device

Median has received the FDA's feedback following the 513(g) regulatory submission for its iBiopsy LCS CADe/CADx Software as Medical Device. Median will proceed through a 510(k) submission

United statesFrance generalCade cadxEmmanuelle leyguesLcs cade cadxGhislaine gasparettoCaroline carmagnolRadiological computer assisted detection and diagnosis softwareHead of corporate marketing financial communicationsSoftware as medical device saAi software as medical deviceDrug administrationBiopsy cade cadx software as medical deviceUnited states foodBiopsy lung cancer screeningMedical device

vimarsana © 2020. All Rights Reserved.